{"id":"NCT01225562","sponsor":"AstraZeneca","briefTitle":"Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin","officialTitle":"A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2010-10-21","resultsPosted":"2015-12-09","lastUpdate":"2016-01-25"},"enrollment":21379,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Myocardial Infarction","Cardiovascular Death","Atherothrombosis","Stroke"],"interventions":[{"type":"DRUG","name":"Ticagrelor 90 mg","otherNames":[]},{"type":"DRUG","name":"Ticagrelor 60 mg","otherNames":[]},{"type":"DRUG","name":"Ticagrelor Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke).","primaryOutcome":{"measure":"Kaplan-Meier Estimate of the Percentage of Patients Who Experienced Cardiovascular Death (CV Death), Myocardial Infarction (MI) or Stroke Within 3 Years From Randomization","timeFrame":"Randomization up to 47 months","effectByArm":[{"arm":"Ticagrelor 90 mg","deltaMin":7.8,"sd":null},{"arm":"Ticagrelor 60 mg","deltaMin":7.8,"sd":null},{"arm":"Placebo","deltaMin":9,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0080"},{"comp":"OG001 vs OG002","p":"0.0043"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":827,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Chile","China","Colombia","Czechia","France","Germany","Hungary","Italy","Japan","Netherlands","Norway","Peru","Philippines","Poland","Romania","Russia","Slovakia","South Africa","South Korea","Spain","Sweden","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["25773268","36367709","35224730","34423649","33559485","32410485","32366163","31811715","31218354","30571502","29406853","29084737","28882235","28750695","28300867","27576775","27438319","27160944","27046162","27046160","26491109","24655690"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=489&filename=D5132C00001_CSP1.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":1757,"n":6996},"commonTop":["Dyspnoea","Nasopharyngitis","Epistaxis","Increased tendency to bruise","Contusion"]}}